The Vanguard Group 13D and 13G filings for GoodRx Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 4:02 pm Unchanged |
2024-09-30 | 13G | GoodRx Holdings, Inc. GDRX |
The Vanguard Group | 7,912,286 8.020% |
0 (Unchanged) |
Filing |
| 2024-11-04 11:58 am Sale |
2024-09-30 | 13G | GoodRx Holdings, Inc. GDRX |
The Vanguard Group | 7,912,286 8.020% |
-468,704 (-5.59%) |
Filing |
| 2024-02-13 5:06 pm Purchase |
2023-12-29 | 13G | GoodRx Holdings, Inc. GDRX |
The Vanguard Group | 8,380,990 9.070% |
62,685 (+0.75%) |
Filing |
| 2023-03-10 07:59 am Purchase |
2023-02-28 | 13G | GoodRx Holdings, Inc. GDRX |
The Vanguard Group | 8,318,305 10.090% |
489,672 (+6.25%) |
Filing |
| 2023-02-09 11:19 am Purchase |
2022-12-30 | 13G | GoodRx Holdings, Inc. GDRX |
The Vanguard Group | 7,828,633 9.490% |
1,777,768 (+29.38%) |
Filing |
| 2022-02-10 08:16 am Purchase |
2021-12-31 | 13G | GoodRx Holdings, Inc. GDRX |
The Vanguard Group | 6,050,865 7.500% |
2,603,999 (+75.55%) |
Filing |
| 2021-02-10 10:57 am Purchase |
2020-12-31 | 13G | GoodRx Holdings, Inc. GDRX |
The Vanguard Group | 3,446,866 7.660% |
3,446,866 (New Position) |
Filing |